CAROLINE BARTELSMEYER: Open Payments
NPI 1477175578 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 65 payments from 29 companies in 2025. Trend: 2023 $982 · 2024 $1,199 · 2025 $1,459
Food & beverage: $1,459
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $170 |
| Genentech USA, Inc. | 6 | $159 |
| Merck Sharp & Dohme LLC | 5 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| TerSera Therapeutics LLC | 2 | $68 |
| Eisai Inc. | 3 | $67 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $60 |
Products named: KEYTRUDA, Tecentriq, DARZALEX, LIBTAYO, Lenvima, ENJAYMO, Polivy, FRUZAQLA.
Industry payments across MO — which companies pay providers there.
